Sec. 701. NIH Innovation Initiatives
759 words·~3 min read·
/bill/116/hr/3/pcs/section-701A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 1001(b) of the 21st Century Cures Act ( Public Law 114–255 ) is amended by adding at the end the following: In addition to the funds made available under paragraph (2), there are authorized to be appropriated, and are hereby appropriated, to the Account, out of any monies in the Treasury not otherwise appropriated, to be available until expended without further appropriation, the following: For fiscal year 2021, $255,400,000. For fiscal year 2022, $260,400,000. For fiscal year 2023, $163,400,000.
For fiscal year 2024, $547,000,000. For fiscal year 2025, $848,000,000. For fiscal year 2026, $842,400,000. For fiscal year 2027, $1,089,600,000. For fiscal year 2028, $1,115,600,000. For fiscal year 2029, $1,170,600,000. For fiscal year 2030, $1,207,600,000. Of the total amounts made available under subparagraph
(A)for each of fiscal years 2021 through 2030, a total amount not to exceed the following shall be made available for the following categories of NIH Innovation Projects: For projects described in paragraph (4)(A), an amount not to exceed a total of $2,070,600,000 as follows: For each of fiscal years 2021 and 2022, $50,000,000. For fiscal year 2024, $100,000,000. For each of fiscal years 2025 and 2026, $300,000,000. For each of fiscal years 2027 through 2029, $317,000,000. For fiscal year 2030, $319,600,000. For projects described in paragraph (4)(B), an amount not to exceed a total of $2,041,900,000 as follows: For each of fiscal years 2021 and 2022, $50,000,000. For fiscal year 2024, $128,000,000. For fiscal year 2025, $209,000,000. For fiscal year 2026, $100,000,000. For fiscal year 2027, $325,000,000. For fiscal year 2028, $350,000,000. For fiscal year 2029, $400,000,000. For fiscal year 2030, $429,900,000. For projects described in paragraph (4)(C), an amount not to exceed a total of $1,558,400,000 as follows: For each of fiscal years 2024 and 2025, $151,200,000. For each of fiscal years 2026 through 2030, $251,200,000. For projects described in paragraph (4)(D), an amount not to exceed $15,400,000 for each of fiscal years 2021 through 2030. In addition to funding NIH Innovation Projects pursuant to subparagraph (B), of the total amounts made available under subparagraph (A), a total amount not to exceed the following shall be made available for the following categories of NIH Innovation Projects: To support research related to combating antimicrobial resistance and antibiotic resistant bacteria, including research into new treatments, diagnostics, and vaccines, research, in consultation with the Centers for Disease Control and Prevention, into stewardship, and the development of strategies, in coordination with the Biomedical Advanced Research and Development Authority under section 319L of the Public Health Service Act, to support commercialization of new antibiotics, not to exceed a total of 1,144,500,000, as follows: For each of fiscal years 2021 through 2024, $100,000,000. For each of fiscal years 2025 and 2026, $120,000,000. For each of fiscal years 2027 through 2029, $125,000,000. For fiscal year 2030, $129,500,000. To support research and research activities related to rare diseases or conditions, including studies or analyses that help to better understand the natural history of a rare disease or condition and translational studies related to rare diseases or conditions, not to exceed a total of $530,600,000, as follows: For fiscal year 2021, $40,000,000. For fiscal year 2022, $45,000,000. For fiscal year 2023, $48,000,000. For each of fiscal years 2024 and 2025, $52,400,000. For fiscal year 2026, $55,800,000. For fiscal year 2027, $56,000,000. For fiscal year 2028, $57,000,000. For each of fiscal years 2029 and 2030, $62,000,000. . Section 1001 of the 21st Century Cures Act ( Public Law 114–255 ) is amended— in subsection (a), by striking subsection (b)(4) and inserting subsections (b)(4) and (b)(5) ; in subsection (b)(1), by striking paragraph
(4)and inserting paragraphs
(4)and
(5); and in subsection (c)(2)(A)(ii), by inserting or pursuant to subsection (b)(5) after subsection (b)(3) ; and in subsection (d), by inserting or pursuant to subsection (b)(5) after subsection (b)(3) . Section 1001(c)(1) of the 21st Century Cures Act ( Public Law 114–255 ) is amended by adding at the end the following: The Director of NIH shall , after seeking recommendations in accordance with the process described in subparagraph (C), update the work plan submitted under this subsection for each of fiscal years 2021 through 2030 to reflect the amendments made to this section by the Elijah E. Cummings Lower Drug Costs Now Act. . Section 1001(c)(2)(A) of the 21st Century Cures Act ( Public Law 114–255 ) is amended by striking 2027 and inserting 2030 . Section 1001(e) of the 21st Century Cures Act ( Public Law 114–255 ) is amended by striking September 30, 2026 and inserting September 30, 2030 .
Connectionstraces to 1
Traces to 1 document
public-private-law
Citation graph
cites case law
Sec. 701
NIH Innovation Initiatives
Cites 1Cited by 0 across 0 sources